Karyopharm Therapeutics | KPTI - Interest Income


Karyopharm Therapeutics reported $-0.15 in Interest Income for its fiscal quarter ending in December of 2024.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
Abbott USD 77M 6M Sep/2025
AstraZeneca USD 85M 17M Sep/2025
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Eli Lilly USD 65M 25M Sep/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Incyte USD 26.78M 1.64M Sep/2025
J&J USD 2.12 0.17 Sep/2025
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 1.53M 114K Sep/2025
Merck USD 96M 27M Sep/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pfizer USD 0.62 156M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Takeda JPY 87.87B 43.48B Dec/2025
Tectonic Therapeutic USD 1.74M 217K Dec/2024
Ultragenyx Pharmaceutical USD 5.79M 1.04M Jun/2025
Xencor USD 7.25M 290K Jun/2025